Managers / Q4 2020 · view latest →
Westhampton Capital, LLC
CIK 0001639997 · 2150 COUNTRY CLUB ROAD, SUITE 250, WINSTON-SALEM, NC, 27104 · 336-725-5579
Summary
Westhampton Capital, LLC reported $134M in U.S.-listed holdings across 103 positions for Q4 2020.
Its largest position, AAPL, represents 10.8% of the portfolio.
Compared with Q3 2020, the fund opened 3 new positions and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 92.0% · $123M
- Other · 4.4% · $6M
- ADR · 2.0% · $3M
- REIT · 1.1% · $1M
- ETP · 0.5% · $699,000
- Other · 0.0% · $8,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| WFCWELLS FARGO CO NEW | NEW | +8.4K | 8.4K | +$253,000 | $253,000 |
| T7DTRANSDIGM GROUP INC | NEW | +402 | 402 | +$249,000 | $249,000 |
| ISHARES TR | NEW | +1.3K | 1.3K | +$202,000 | $202,000 |
| NEENEXTERA ENERGY INC | ADDED | +8.3K | 10.7K | +$160,000 | $825,000 |
| BIIBBIOGEN INC | SOLD OUT | −1.7K | 0 | −$471,000 | $0 |
| FDXFEDEX CORP | SOLD OUT | −867 | 0 | −$218,000 | $0 |
| MCXMCCORMICK & CO INC | ADDED | +13.1K | 26.1K | −$38,000 | $2M |
| CVSCVS HEALTH CORP | TRIMMED | −3.8K | 4.1K | −$181,000 | $281,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $214M | 129 | Apr 16, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $212M | 122 | Jan 30, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $205M | 120 | Oct 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $194M | 116 | Jul 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $183M | 114 | Apr 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $196M | 119 | Jan 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $197M | 115 | Oct 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $184M | 116 | Jul 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $183M | 118 | Apr 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $168M | 117 | Jan 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $155M | 116 | Oct 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $154M | 112 | Jul 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $156M | 114 | Apr 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $148M | 115 | Jan 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $133M | 108 | Oct 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $142M | 113 | Aug 12, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2022 | $155M | 115 | May 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $163M | 114 | Jan 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $146M | 112 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $154M | 109 | Aug 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $145M | 109 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $134M | 103 | Feb 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $122M | 102 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $115M | 105 | Jul 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $96M | 96 | Apr 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $123M | 110 | Jan 30, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $120M | 109 | Oct 16, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $119M | 110 | Aug 6, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.